Sickle Cell Disease


Upon viewing this session, you will be able to:

• review new data on end-organ complications in SCD
• outline potential for decreased admission through use of day infusion clinics
• describe outcomes associated with novel SCD therapies such as L-glutamine, Voxelotor
• explore advances in curative therapies such as gene replacement therapy, gene editing, hematopoietic stem cell transplant
• outline improvements in hydroxyurea management


  • Deepa Manwani


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top